Skip to main content
. 2012 Feb;26(2):604–616. doi: 10.1096/fj.11-191510

Table 1.

Pharmacological properties of Cys-substituted mutant M3Rs

Receptor Ballesteros- Weinstein number [3H]-NMS binding
Carbachol binding, Ki (μM) Carbachol-induced inositol monophosphate production
KD (nM) Bmax (pmol/mg protein) EC50 (nM) Emax (fold above basal) Basal activity (%)
M3′(3C)-Xa 1.45 ± 0.17 9.29 ± 0.35 34.3 ± 4.8 47 ± 14 4.5 ± 0.7 100
R252C 5.60 1.68 ± 0.33 3.51 ± 0.35 67.5 ± 14.5 127 ± 28 3.6 ± 1.5 92 ± 13
I253C 5.61 1.84 ± 0.53 7.63 ± 2.21 74.4 ± 22.7 177 ± 56 4.8 ± 2.6 91 ± 9
Y254C 5.62 1.50 ± 0.51 4.83 ± 1.47 48.8 ± 5.9 338 ± 101 4.0 ± 2.6 112 ± 34
K255C 5.63 0.91 ± 0.26 9.58 ± 1.13 41.3 ± 0.2 56 ± 13 3.9 ± 2.0 78 ± 14
E256C 5.64 1.59 ± 0.54 6.26 ± 0.64 12.2 ± 1.6 9.7 ± 2.2 4.5 ± 1.6 132 ± 42
T257C 5.65 1.05 ± 0.48 7.96 ± 1.14 33.5 ± 5.7 16 ± 6.9 2.9 ± 0.7 103 ± 9
E258C 5.66 1.02 ± 0.65 8.73 ± 1.06 22.2 ± 7.9 5.3 ± 2.0 4.4 ± 0.1 203 ± 40
K259C 5.67 0.98 ± 0.47 8.25 ± 0.70 25.2 ± 3.0 24 ± 6.8 3.1 ± 0.6 86 ± 20
R260C 5.68 0.91 ± 0.48 6.57 ± 0.98 36.9 ± 6.3 436 ± 180 2.2 ± 1.0 73 ± 17
T261C 5.69 0.86 ± 0.33 7.83 ± 0.91 33.7 ± 6.6 62 ± 13 2.9 ± 0.4 83 ± 24
K262C 5.70 0.87 ± 0.15 5.41 ± 0.16 62.4 ± 16.9 11 ± 2.6 2.8 ± 1.1 70 ± 4
E263C 5.71 1.16 ± 0.31 6.16 ± 0.54 26.8 ± 1.0 10 ± 5.6 2.7 ± 0.7 78 ± 13
L264C 5.72 1.24 ± 0.23 6.64 ± 0.22 20.9 ± 0.8 17 ± 4.6 2.8 ± 0.5 70 ± 13
A265C 5.73 1.38 ± 0.28 8.24 ± 0.58 48.2 ± 3.8 11 ± 6.5 3.1 ± 0.2 64 ± 2

COS-7 cells were transiently transfected with the indicated M3′(3C)-Xa-derived Cys-substituted mutant M3R (rat) constructs. Radioligand binding and PI assays were performed and analyzed as described in Materials and Methods. Basal inositol monophosphate levels for the M3′ (3C)-Xa construct were 11,043 ± 1891 dpm (=100%). Data are shown as means ± se of 2–4 independent experiments.